DEF 14A

Company

Revolution Medicines, Inc.

Filed

April 26, 2023

Accession Number

0001193125-23-118577

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →